Work

The role of hydroxychloroquine in COVID-19: Where do we stand?

Year: 2020

Type: article

Abstract: Hydroxychloroquine (HCQ) is a drug, which has long been used in the treatment of malaria, rheumatoid arthritis, systemic lupus erythematosus, and Sjogren's syndrome. Recently with the COVID-19 pandemic hitting the world, there have been studies suggesting that hydroxychloroquine may be useful both in the prevention and the treatment of COVID-19, although the evidence so far has been conflicting. This article reviews the available evidence for the use of hydroxychloroquine in COVID-19 and also mentions some of the ongoing trials in this field.

Source: Journal of Diabetology

DOI: 10.4103/jod.jod_33_20

Authors: RanjitMohan Anjana, NadimintyGanapathi Sastry, Muthu Ramuu, PrasannaKumar Gupta, Jaggi Shalini, BrijendraKumar Srivastava, ChaithanyaMurthy Kocherlakota, TataSameer Nandan, Gangadhara Praveen, Jyotish Nair, Routray Philips, Viswanathan Mohan, Ranjit Unnikrishnan

Institutions: Madras Diabetes Research Foundation, Dr. Mohan's Diabetes Specialities Centre

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W3041912927

FWCI:

Cites:

Cited by:

Related to: 10